MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins
Graphical abstract
Section snippets
Acknowledgments
Thanks to the Spanish Ministry (PS09/00501) and to Xunta de Galicia (PGIDIT09CSA030203PR and 10PXIB203303PR). M.J.M. thanks FCT for a PhD grant (SFRH/BD/61262/2009). S.V.R. thanks to Ministerio de Educación y Ciencia for a PhD grant (AP2008-04263).
References and notes (53)
- et al.
Gen. Pharmacol.
(1996) Prog. Chem. Org. Nat. Prod.
(2002)Eur. J. Med. Chem.
(2007)- et al.
Bioorg. Med. Chem.
(2007) - et al.
Bioorg. Med. Chem.
(2010) - et al.
Bioorg. Med. Chem. Lett.
(2010) - et al.
Bioorg. Med. Chem.
(2004) - et al.
Bioorg. Med. Chem.
(2004) - et al.
Bioorg. Med. Chem. Lett.
(2009) - et al.
Bioorg. Med. Chem. Lett.
(2009)
Bioorg. Med. Chem. Lett.
(2010)
Eur. J. Med. Chem.
(2011)
J. Mol. Biol.
(2004)
Pharmacol. Ther.
(1990)
Am. J. Geriatr. Pharmacother.
(2006)
Neurotoxicology
(2004)
Tetrahedron
(2001)
Bioorg. Med. Chem. Lett.
(2006)
Biochem. Biophys. Res. Comm.
(2006)
Curr. Med. Chem.
(2005)
Front Med. Chem.
(2009)
Curr. Med. Chem.
(2005)
Enzyme Inhib. Med. Chem.
(2003)
Antimicrob. Agents Chemother.
(2007)
J. Med. Chem.
(2009)
Curr. HIV Res.
(2006)
Cited by (0)
Copyright © 2011 Elsevier Ltd. All rights reserved.